AC T14649
XX
ID T14649
XX
DT 10.03.2005 (created); nvo.
DT 09.02.2016 (updated); mom.
CO Copyright (C), QIAGEN.
XX
FA WT1
XX
SY Wilms' tumor protein.
XX
OS Mammalia
OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia
XX
IN T16760 p63; Mammalia.
IN T16759 p73; Mammalia.
IN T33899 ZNF224; Mammalia.
XX
MX M07436 V$WT1_Q4.
MX M01118 V$WT1_Q6.
MX M02036 V$WT1_Q6_01.
MX M03893 V$WT1_Q6_02.
XX
BS R25100.
BS R37270.
BS R32531.
BS R39490.
BS R32507.
BS R32508.
BS R35703.
BS R35704.
BS R24925.
BS R71754.
BS R32530.
BS R42265.
BS R42267.
BS R42268.
BS R42272.
BS R42274.
BS R42275.
BS R71747.
BS R71752.
BS R71746.
BS R36892.
BS R67904.
BS R67905.
BS R30306.
BS R32519.
BS R28704.
BS R62841.
BS R62848.
BS R32522.
BS R60377.
BS R33247.
BS R42512.
BS R65801.
BS R65802.
BS R65804.
BS R65805.
BS R32514.
BS R39723.
XX
DR TRANSPATH: MO000047181.
XX
RN [1]; RE0024381.
RX PUBMED: 10744705.
RA Scharnhorst V., Dekker P., van der Eb A. J., Jochemsen A. G.
RT Physical interaction between Wilms tumor 1 and p73 proteins modulates their functions.
RL J. Biol. Chem. 275:10202-10211 (2000).
RN [2]; RE0038248.
RX PUBMED: 12239212.
RA Lee T. H., Lwu S., Kim J., Pelletier J.
RT Inhibition of Wilms tumor 1 transactivation by bone marrow zinc finger 2, a novel transcriptional repressor
RL J. Biol. Chem. 277:44826-37 (2002).
RN [3]; RE0038515.
RX PUBMED: 12923058.
RA Reynolds P. A., Smolen G. A., Palmer R. E., Sgroi D., Yajnik V., Gerald W. L., Haber D. A.
RT Identification of a DNA-binding site and transcriptional target for the EWS-WT1(+KTS) oncoprotein
RL Genes Dev. 17:2094-107 (2003).
RN [4]; RE0039847.
RX PUBMED: 11001926.
RA Little N. A., Hastie N. D., Davies R. C.
RT Identification of WTAP, a novel Wilms' tumour 1-associating protein
RL Hum. Mol. Genet. 9:2231-9 (2000).
RN [5]; RE0040235.
RX PUBMED: 14666652.
RA Zhang T. F., Yu S. Q., Guan L. S., Wang Z. Y.
RT Inhibition of breast cancer cell growth by the Wilms' tumor suppressor WT1 is associated with a destabilization of beta-catenin
RL Anticancer Res. 23:3575-84 (2003).
RN [6]; RE0040402.
RX PUBMED: 8622864.
RA Martinerie C., Chevalier G., Rauscher F. J. 3rd, Perbal B.
RT Regulation of nov by WT1: a potential role for nov in nephrogenesis
RL Oncogene 12:1479-92 (1996).
RN [7]; RE0043599.
RX PUBMED: 10753894.
RA Hosono S., Gross I., English M. A., Hajra K. M., Fearon E. R., Licht J. D.
RT E-cadherin is a WT1 target gene
RL J. Biol. Chem. 275:10943-53 (2000).
RN [8]; RE0044535.
RX PUBMED: 14701728.
RA Carpenter B., Hill K. J., Charalambous M., Wagner K. J., Lahiri D., James D. I., Andersen J. S., Schumacher V., Royer-Pokora B., Mann M., Ward A., Roberts S. G.
RT BASP1 is a transcriptional cosuppressor for the Wilms' tumor suppressor protein WT1
RL Mol. Cell. Biol. 24:537-49 (2004).
RN [9]; RE0045611.
RX PUBMED: 9556563.
RA Johnstone R. W., Wang J., Tommerup N., Vissing H., Roberts T., Shi Y.
RT Ciao 1 is a novel WD40 protein that interacts with the tumor suppressor protein WT1
RL J. Biol. Chem. 273:10880-7 (1998).
RN [10]; RE0046115.
RX PUBMED: 8895526.
RA Cook D. M., Hinkes M. T., Bernfield M., Rauscher F. J. 3rd.
RT Transcriptional activation of the syndecan-1 promoter by the Wilms' tumor protein WT1
RL Oncogene 13:1789-99 (1996).
RN [11]; RE0047681.
RX PUBMED: 9372952.
RA Qi J. S., Desai-Yajnik V., Yuan Y., Samuels H. H.
RT Constitutive activation of gene expression by thyroid hormone receptor results from reversal of p53-mediated repression.
RL Mol. Cell. Biol. 17:7195-7207 (1997).
RN [12]; RE0047964.
RX PUBMED: 14603255.
RA Discenza M. T., He S., Lee T. H., Chu L. L., Bolon B., Goodyer P., Eccles M., Pelletier J.
RT WT1 is a modifier of the Pax2 mutant phenotype: cooperation and interaction between WT1 and Pax2.
RL Oncogene 22:8145-8155 (2003).
RN [13]; RE0049487.
RX PUBMED: 16934801.
RA Markus M. A., Heinrich B., Raitskin O., Adams D. J., Mangs H., Goy C., Ladomery M., Sperling R., Stamm S., Morris B. J.
RT WT1 interacts with the splicing protein RBM4 and regulates its ability to modulate alternative splicing in vivo.
RL Exp. Cell Res. 312:3379-3388 (2006).
XX
//